Siegel, G <br/><br/>
The effect of an HMG-CoA reductase inhibitor on arteriosclerotic nanoplaque formation and size in a biosensor model.  [electronic resource] 

 -  Biosensors & bioelectronics  May 2003 
 - 635-47 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0956-5663 
<br/><br/><label>Standard No.: </label>10.1016/s0956-5663(03)00034-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adsorption<br/>Arteriosclerosis--blood<br/>Biosensing Techniques--methods<br/>Calcinosis--blood<br/>Calcium--metabolism<br/>Coated Materials, Biocompatible--chemical synthesis<br/>Diabetes Mellitus, Type 2--complications<br/>Fatty Acids, Monounsaturated--therapeutic use<br/>Fluvastatin<br/>Heparan Sulfate Proteoglycans--chemistry<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Hypolipidemic Agents--therapeutic use<br/>Indoles--therapeutic use<br/>Lipoproteins--blood<br/>Materials Testing<br/>Models, Biological<br/>Particle Size<br/>Silicon Dioxide--metabolism<br/>Surface Properties--drug effects<br/>Treatment Outcome